European Union

Glaxo’s ‘Cervarix’ Gets EU Authorization

London: GlaxoSmithKline PLC’s cervical cancer vaccine ‘Cervarix’ has received nod for sale across the European Union.

The vaccine has been sanctioned to avert pre-cancerous wounds and cervical cancer caused by human papillomavirus types 16 and 18 that held responsible for over 70 per cent of all cervical cancer cases.

The world’s second-biggest drug manufacturer said that the indication for Cervarix is based on statistics developed by clinical studies in girls and young women between 10 and 25.

US, EU concerned over arrests of Pak opposition leaders

Islamabad, Sep 25: The United States and the European Union are concerned over the recent arrests and detention of leaders of the opposition parties ahead of the presidential election on October 6.

A US embassy statement stated that reports of the detention of the leadership of several major Pakistani political parties are "extremely disturbing and confusing" for the "friends of Pakistan".

Major Set-back for Microsoft in EU Antitrust Case

Euro Hits New Record Against Dollar

Euro Coins and Banknotes

EU Approves Roche’s Avastin For Cancer

Avastin MedicineBASEL: According to the world’s biggest maker of cancer drugs, Roche Holding AG